title: Point/Counterpoint. Evaluation of treatment plans using target and normal tissue DVHs is no longer appropriate.
authors.affiliation: California Cancer Center, Fresno, California 93720 (Tel: 903-422-0449; E-mail: christopher.njeh@natmedphysics.com).
authors.forename: Christopher F
authors.initials: CF
authors.lastname: Njeh
authors.affiliation: Department of Radiation Oncology, University of Texas Medical Branch at Galveston, Galveston, Texas 77555-0711 (Tel: 409-772-6560; E-mail: bcparker@utmb.edu).
authors.forename: Brent C
authors.initials: BC
authors.lastname: Parker
authors.forename: Colin G
authors.initials: CG
authors.lastname: Orton
mesh_terms: D006801:Humans; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*